Medical Communications
New monoclonal antibody for hospitalised COVID-19 patients approved by FDA
December 22, 2022 Medical Communications
The FDA has approved Roche’s monoclonal antibody which treats hospitalised adult patients with COVID-19. The antibody, Actemra, is already approved …
Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery
December 21, 2022 Medical Communications
LONDON, UK, 21st December 2022 — RQ Bio announces that the first of its discovered monoclonal antibodies to prevent COVID-19 …
Kite set to acquire Tmunity Therapeutics
December 21, 2022 Medical Communications
Santa Monica, US-based Kite is set to acquire Philadelphia, US-based Tmunity Therapeutics: a clinical stage, private biotech company. The financial …
Two biotech CEOs charged with defrauding investors over investigational HIV drug
December 21, 2022 Medical Communications
Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company …
Gambia panel recommends Maiden Pharmaceuticals be held culpable for cough syrup deaths
December 21, 2022 Medical Communications
A parliamentary committee in The Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as they have sold …
Tamiflu manufacturers report shortages during high point of flu season
December 21, 2022 Medical Communications
The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high …
ServBlock secures EU funding for pharma manufacturing data space
December 20, 2022 Medical Communications
ServBlock, an Irish start-up, and Irish Manufacturing Research (IMR), have been given EU funding to build a data exchange system …
Abbott’s Eterna spinal cord stimulation system given FDA approval
December 20, 2022 Medical Communications
US-based Abbott Laboratories has announced that their Eterna spinal cord stimulation (SCS) system has been given approval by the FDA. …
Unison boss states Government has “adamantly refused” to engage in a “proper discussion” on pay ahead of Wednesday’s ambulance strikes
December 19, 2022 Medical Communications
Unison general secretary Christina McAnea has said that Wednesday’s ambulance strikes will go ahead without a “very firm commitment” on …
FDA approves first gene therapy to treat patients with high-risk, non-muscle-invasive bladder cancer
December 19, 2022 Medical Communications
The FDA has approved Adstiladrin (scientific name nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive …
Anumana and Pfizer team up on AI-enabled ECG algorithm for detection of cardiovascular disease
December 16, 2022 Medical Communications
Anumana, an AI-driven health technology firm, has signed a multi-year deal with Pfizer in order to develop an AI electrocardiogram …
Eli Lilly and Sosei Heptares enter into multi-target collaboration and license agreement for diabetes and metabolic diseases
December 16, 2022 Medical Communications
Japan-based Sosei Heptares announced that it has joined forces with UK global biopharma company Eli Lilly to discover, develop and …
Johnson & Johnson and Merck’s Ebola vaccines show lasting protection
December 15, 2022 Medical Communications
The two Ebola vaccines developed by Johnson & Johnson and Merck appeared successful according to two studies: they both produced …
European Commission approves Dupixent® as the first and only targeted medicine for prurigo nodularis
December 15, 2022 Medical Communications
Regeneron Pharmaceuticals and Sanofi have announced that the European Commission (EC) has expanded the marketing authorisation for Dupixent® (dupilumab) in …
LumiraDx receives $14m in funding for point-of-care TB test
December 15, 2022 Medical Communications
UK-based point-of-care diagnostics company LumiraDx has been given $14m in grants from the Bill & Melinda Gates Foundation to support …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
